Two Sigma Advisers’s scPharmaceuticals SCPH Stock Holding History

Two Sigma Advisers’s Portfolio SCPH Stock Details SCPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-18,000	Closed	-$183K	–	2558
2023 Q2	$183K	Sell	18,000 -121,700	-87%	-$1.27M	﹤0.01%	2115
2023 Q1	$1.27M	Buy	139,700 +43,400	+45%	+$318K	﹤0.01%	1510
2022 Q4	$690K	Buy	+96,300	New	+$588K	﹤0.01%	1741
2021 Q3	–	Sell	-11,000	Closed	-$67K	–	2648
2021 Q2	$67K	Sell	11,000 -700	-6%	-$4.22K	﹤0.01%	2369
2021 Q1	$78K	Sell	11,700 -1,300	-10%	-$8.91K	﹤0.01%	2466
2020 Q4	$69K	Sell	13,000 -2,000	-13%	-$15.7K	﹤0.01%	2298
2020 Q3	$112K	Buy	+15,000	New	+$117K	﹤0.01%	2261

Other funds holding SCPH

OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return

RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return

RCMNY

Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return

ACM

AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return

CAC

Cowen and Company New York $2.97B AUM 105.26% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

5VM

5AM Venture Management San Francisco, California $288M AUM 313.93% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Thrivent Financial for Lutherans Minneapolis, Minnesota $59.5B AUM 35.96% 1-Year Est. Return

Two Sigma Advisers's SCPH Position: Q3 2023 in Review

Two Sigma Advisers sold out of scPharmaceuticals (SCPH) in Q3 2023, closing a stake of 18,000 shares — an estimated $183K sold.

Two Sigma Advisers first reported a position in SCPH in Q3 2020 and held it in 7 quarters. The position peaked at $1.27M in Q1 2023. 73 funds tracked by Wall St. Rank hold SCPH as of Q3 2023.

Two Sigma Advisers reported no remaining scPharmaceuticals position as of Q3 2023 after selling out during the quarter.
Two Sigma Advisers sold 18,000 scPharmaceuticals shares in Q3 2023, an estimated $183K.
Two Sigma Advisers first reported a position in scPharmaceuticals in Q3 2020 and held it in 7 quarters.
Two Sigma Advisers's scPharmaceuticals position peaked at $1.27M in Q1 2023.
73 funds tracked by Wall St. Rank held scPharmaceuticals as of Q3 2023.

Based on Two Sigma Advisers's 13F filing for Q3 2023, filed 14 Nov 2023.